Zeng, W.; Zhou, X.; Yu, S.; Liu, R.; Quek, C.W.N.; Yu, H.; Tay, R.Y.K.; Lin, X.; Feng, Y.
The Future of Targeted Treatment of Primary Sjögren’s Syndrome: A Focus on Extra-Glandular Pathology. Int. J. Mol. Sci. 2022, 23, 14135.
https://doi.org/10.3390/ijms232214135
AMA Style
Zeng W, Zhou X, Yu S, Liu R, Quek CWN, Yu H, Tay RYK, Lin X, Feng Y.
The Future of Targeted Treatment of Primary Sjögren’s Syndrome: A Focus on Extra-Glandular Pathology. International Journal of Molecular Sciences. 2022; 23(22):14135.
https://doi.org/10.3390/ijms232214135
Chicago/Turabian Style
Zeng, Weizhen, Xinyao Zhou, Sulan Yu, Ruihua Liu, Chrystie Wan Ning Quek, Haozhe Yu, Ryan Yong Kiat Tay, Xiang Lin, and Yun Feng.
2022. "The Future of Targeted Treatment of Primary Sjögren’s Syndrome: A Focus on Extra-Glandular Pathology" International Journal of Molecular Sciences 23, no. 22: 14135.
https://doi.org/10.3390/ijms232214135
APA Style
Zeng, W., Zhou, X., Yu, S., Liu, R., Quek, C. W. N., Yu, H., Tay, R. Y. K., Lin, X., & Feng, Y.
(2022). The Future of Targeted Treatment of Primary Sjögren’s Syndrome: A Focus on Extra-Glandular Pathology. International Journal of Molecular Sciences, 23(22), 14135.
https://doi.org/10.3390/ijms232214135